Evaluation and treatment of erectile dysfunction
- PMID: 21095423
- DOI: 10.1016/j.mcna.2010.08.016
Evaluation and treatment of erectile dysfunction
Abstract
Erectile dysfunction (ED) is a prevalent and important disease that has been associated with various comorbidities. The evaluation of patients with ED should include a general health assessment followed by a discussion of reversible factors and lifestyle changes that might help preserve erectile capacity. Numerous effective treatment options are currently available. A frank discussion about use and side effects of these therapies is required to optimize success. Although oral pharmacologic treatments can be initiated and monitored by the primary care physician, patients who do not experience response to these treatments may be best served by referral to a sexual medicine specialist for further assessment and consideration of other treatment options. This article discusses the physiology and pathophysiology of erectile function in men, how the primary care physician may address the clinical problem of ED in practice, and when specialty referral is indicated.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Evaluation and treatment of erectile dysfunction in the aging male: a mini-review.Gerontology. 2012;58(1):3-14. doi: 10.1159/000329598. Epub 2011 Sep 7. Gerontology. 2012. PMID: 21912081
-
Core document on erectile dysfunction: key aspects in the care of a patient with erectile dysfunction.Int J Impot Res. 2004 Oct;16 Suppl 2:S26-39. doi: 10.1038/sj.ijir.3901240. Int J Impot Res. 2004. PMID: 15496854 Review.
-
Erectile Dysfunction.Prim Care. 2019 Jun;46(2):249-255. doi: 10.1016/j.pop.2019.02.006. Epub 2019 Apr 1. Prim Care. 2019. PMID: 31030826 Review.
-
The management of erectile dysfunction in the community.Int J Impot Res. 2001 Aug;13 Suppl 3:S45-51. doi: 10.1038/sj.ijir.3900723. Int J Impot Res. 2001. PMID: 11477492 Review.
-
Recent advances in the understanding and management of erectile dysfunction.F1000Res. 2019 Jan 25;8:F1000 Faculty Rev-102. doi: 10.12688/f1000research.16576.1. eCollection 2019. F1000Res. 2019. PMID: 30740217 Free PMC article. Review.
Cited by
-
The sexual functions of male patients suffering from affective disorders.Postep Psychiatr Neurol. 2024 Jun;33(2):54-58. doi: 10.5114/ppn.2024.141052. Epub 2024 Jul 10. Postep Psychiatr Neurol. 2024. PMID: 39119545 Free PMC article.
-
Carotid artery intima media thickness can predict the response to phosphodiesterase 5 inhibitors in patients with moderate erectile dysfunction.Sex Med. 2023 Jul 31;11(3):qfad042. doi: 10.1093/sexmed/qfad042. eCollection 2023 Jun. Sex Med. 2023. PMID: 37529683 Free PMC article. Review.
-
Male Sexual Dysfunction.Health Psychol Res. 2022 Aug 20;10(3):37533. doi: 10.52965/001c.37533. eCollection 2022. Health Psychol Res. 2022. PMID: 35999971 Free PMC article.
-
Urine-Derived Stem Cells Versus Their Lysate in Ameliorating Erectile Dysfunction in a Rat Model of Type 2 Diabetes.Front Physiol. 2022 May 10;13:854949. doi: 10.3389/fphys.2022.854949. eCollection 2022. Front Physiol. 2022. PMID: 35620604 Free PMC article.
-
Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin®) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series.Toxins (Basel). 2022 Apr 16;14(4):286. doi: 10.3390/toxins14040286. Toxins (Basel). 2022. PMID: 35448895 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
